Personalizing an ablation for persistent AF
A multicenter randomized, controlled, double-blind superiority trial tested whether adding AI-detected spatio-temporal electrogram-dispersion targets to pulmonary-vein isolation improves treatment of drug-refractory persistent atrial fibrillation.
Original sources ↓ · Revision history ↓
Demonstrated · source published 2025-02-14
The human problem
Persistent and long-standing persistent atrial fibrillation can remain difficult to treat with a standard anatomical ablation procedure.
The prior constraint
Clinicians need reproducible ways to identify patient-specific electrical patterns that might guide additional ablation targets.
AI’s actual role
An AI algorithm detected areas of spatio-temporal electrogram dispersion for the tailored ablation arm, in addition to pulmonary-vein isolation.
The documented result
At 12 months after a single ablation, 88% of the tailored arm (n=187) versus 70% of the PVI-only arm (n=183) met the primary efficacy endpoint: freedom from documented atrial fibrillation with or without antiarrhythmic drugs (P<0.0001 for superiority).
Why it may matter
The study tests AI-guided targeting against a clinical comparator with a one-year patient outcome, rather than only a retrospective diagnostic metric.
Limitations
There was no significant between-arm difference in freedom from any atrial arrhythmia after one ablation.
Procedure and ablation times were twice as long in the tailored arm.
The results apply to the trial's selected persistent-AF population and procedure context.
Unresolved questions
Do benefits persist over longer follow-up and across broader patient populations?
How do procedure burden, complications, cost, and repeat procedures compare outside the trial?
Source history & evidence assessment
- Maturity
- Demonstrated
- Claim confidence
- unassessed
- Event date
- Not recorded
- Source published
- 2025-02-14
- Captured
- 2026-09-07
- Last source review
- 2026-09-07
- Editorial method
- AI-assisted source review
- Place / relevance
- Not recorded
AI-assisted editorial comparison with the cited primary source; result, setting, source date and limitations retained. Independently checked within the research team. Publication authorized by the site owner; no human source review is claimed.
Maturity describes the tested or operational setting. Confidence describes support for the particular claim; one does not determine the other.
Original sources
Institutions: TAILORED-AF Investigators
Explore the underlying question
Revision & correction history
2026-09-07 · The study tests AI-guided targeting against a clinical comparator with a one-year patient outcome, rather than only a retrospective diagnostic metric.
No corrections recorded.
